Tissue Regenix Group Plc (TRX) — Capital Reinvestment Ratio
Tissue Regenix Group Plc (TRX) has a Capital Reinvestment Ratio of 0.11x as of December 2023, meaning it reinvests 0% of its operating cash flow (GBX1.36 Million) in capital expenditures (GBX153.75K). See Tissue Regenix Group Plc (TRX) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tissue Regenix Group Plc Capital Reinvestment Ratio (2023–2023)
This chart tracks Tissue Regenix Group Plc's Capital Reinvestment Ratio across 1 annual periods. Check Tissue Regenix Group Plc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tissue Regenix Group Plc (2023–2023)
Year-by-year Capital Reinvestment Ratio for Tissue Regenix Group Plc from 2023 to 2023. For live market cap and broader valuation context, see TRX stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.83x | GBX1.04 Million | GBX863.00K | — |